关注
Nyantakyi Samuel Agyei, Ph.D
Nyantakyi Samuel Agyei, Ph.D
EC Postdoctoral Fellow, Umeå universitet
在 umu.se 的电子邮件经过验证
标题
引用次数
引用次数
年份
Amphiphilic indole derivatives as antimycobacterial agents: structure–activity relationships and membrane targeting properties
T Yang, W Moreira, SA Nyantakyi, H Chen, DB Aziz, ML Go, T Dick
Journal of medicinal chemistry 60 (7), 2745-2763, 2017
792017
The mycobacterial membrane: a novel target space for anti-tubercular drugs
H Chen, SA Nyantakyi, M Li, P Gopal, DB Aziz, T Yang, W Moreira, ...
Frontiers in microbiology 9, 1627, 2018
522018
Indolyl azaspiroketal Mannich bases are potent antimycobacterial agents with selective membrane permeabilizing effects and in vivo activity
SA Nyantakyi, M Li, P Gopal, M Zimmerman, V Dartois, M Gengenbacher, ...
Journal of medicinal chemistry 61 (13), 5733-5750, 2018
332018
Indolylalkyltriphenylphosphonium analogues are membrane-depolarizing mycobactericidal agents
M Li, SA Nyantakyi, P Gopal, DB Aziz, T Dick, ML Go
ACS medicinal chemistry letters 8 (11), 1165-1170, 2017
312017
Potency increase of spiroketal analogs of membrane inserting indolyl mannich base antimycobacterials is due to acquisition of MmpL3 inhibition
M Li, ZY Phua, Y Xi, Z Xu, SA Nyantakyi, W Li, M Jackson, MW Wong, ...
ACS infectious diseases 6 (7), 1882-1893, 2020
162020
Amide–amine replacement in indole-2-carboxamides yields potent mycobactericidal agents with improved water solubility
YJ Tan, M Li, GA Gunawan, SA Nyantakyi, T Dick, ML Go, Y Lam
ACS Medicinal Chemistry Letters 12 (5), 704-712, 2020
142020
Resistance against membrane-inserting MmpL3 inhibitor through upregulation of MmpL5 in Mycobacterium tuberculosis
M Li, SA Nyantakyi, ML Go, T Dick
Antimicrobial agents and chemotherapy 64 (12), 10.1128/aac. 01100-20, 2020
32020
Resistance against membrane-inserting MmpL3 inhibitor through upregulation of MmpL5 in M. tuberculosis.
M Li, SA Nyantakyi, ML Go, T Dick
American Society for Microbiology, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–8